chr19-38596432-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001042600.3(MAP4K1):c.1996C>A(p.Pro666Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000487 in 1,438,488 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000049 ( 0 hom. )
Consequence
MAP4K1
NM_001042600.3 missense
NM_001042600.3 missense
Scores
2
11
5
Clinical Significance
Conservation
PhyloP100: 5.65
Genes affected
MAP4K1 (HGNC:6863): (mitogen-activated protein kinase kinase kinase kinase 1) Enables ATP binding activity and MAP kinase kinase kinase kinase activity. Involved in several processes, including JNK cascade; cellular response to phorbol 13-acetate 12-myristate; and protein phosphorylation. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP4K1 | NM_001042600.3 | c.1996C>A | p.Pro666Thr | missense_variant | 26/31 | ENST00000396857.7 | NP_001036065.1 | |
MAP4K1 | NM_007181.6 | c.1996C>A | p.Pro666Thr | missense_variant | 26/32 | NP_009112.1 | ||
MAP4K1 | XM_011526404.2 | c.2116C>A | p.Pro706Thr | missense_variant | 27/32 | XP_011524706.1 | ||
MAP4K1-AS1 | NR_134907.1 | n.86G>T | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP4K1 | ENST00000396857.7 | c.1996C>A | p.Pro666Thr | missense_variant | 26/31 | 5 | NM_001042600.3 | ENSP00000380066.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000487 AC: 7AN: 1438488Hom.: 0 Cov.: 32 AF XY: 0.00000420 AC XY: 3AN XY: 714406
GnomAD4 exome
AF:
AC:
7
AN:
1438488
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
714406
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 17, 2024 | The c.1996C>A (p.P666T) alteration is located in exon 26 (coding exon 26) of the MAP4K1 gene. This alteration results from a C to A substitution at nucleotide position 1996, causing the proline (P) at amino acid position 666 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;.;M
PrimateAI
Pathogenic
T
PROVEAN
Uncertain
.;.;D
REVEL
Uncertain
Sift
Uncertain
.;.;D
Sift4G
Benign
T;T;T
Polyphen
D;.;D
Vest4
MutPred
Gain of catalytic residue at P666 (P = 0.0048);.;Gain of catalytic residue at P666 (P = 0.0048);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -4
Find out detailed SpliceAI scores and Pangolin per-transcript scores at